Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126104641 | 12610464 | 1 | I | 20150922 | 20160726 | 20160801 | 20160801 | EXP | FR-PFIZER INC-2016362287 | PFIZER | 20.00 | YR | M | Y | 0.00000 | 20160801 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126104641 | 12610464 | 1 | PS | ATRACURIUM BESILATE | ATRACURIUM BESYLATE | 1 | Intravenous (not otherwise specified) | UNK | Y | 90782 | SOLUTION FOR INJECTION | ||||||||
| 126104641 | 12610464 | 2 | SS | PROPOFOL. | PROPOFOL | 1 | Intravenous (not otherwise specified) | UNK | Y | 77908 | EMULSION FOR INJECTION | ||||||||
| 126104641 | 12610464 | 3 | SS | VANCOMYCIN SANDOZ | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 2 G, UNK | Y | 0 | 2 | G | |||||||
| 126104641 | 12610464 | 4 | SS | GELOFUSINE | GELATINSODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 500 ML, UNK | Y | 0 | 500 | ML | |||||||
| 126104641 | 12610464 | 5 | SS | GELOFUSINE | GELATINSODIUM CHLORIDE | 1 | Y | 0 | |||||||||||
| 126104641 | 12610464 | 6 | SS | SUFENTANIL MYLAN | SUFENTANIL | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 126104641 | 12610464 | 7 | C | EPREX | ERYTHROPOIETIN | 1 | 4000 IU, WEEKLY ON SATURDAYS | 0 | 4000 | IU | /wk | ||||||||
| 126104641 | 12610464 | 8 | C | INNOHEP | TINZAPARIN SODIUM | 1 | 14000 IU, DAILY | 0 | 14000 | IU | |||||||||
| 126104641 | 12610464 | 9 | C | LACTATED RINGER SOLUTION | 2 | 500 ML, UNK | 0 | 500 | ML |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126104641 | 12610464 | 1 | General anaesthesia |
| 126104641 | 12610464 | 2 | General anaesthesia |
| 126104641 | 12610464 | 3 | Antibiotic prophylaxis |
| 126104641 | 12610464 | 4 | Plasma expander transfusion |
| 126104641 | 12610464 | 5 | Fluid replacement |
| 126104641 | 12610464 | 6 | General anaesthesia |
| 126104641 | 12610464 | 9 | Fluid replacement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126104641 | 12610464 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126104641 | 12610464 | Anaphylactic shock | |
| 126104641 | 12610464 | Hypotension | |
| 126104641 | 12610464 | Oxygen saturation decreased | |
| 126104641 | 12610464 | Rash | |
| 126104641 | 12610464 | Tryptase increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126104641 | 12610464 | 1 | 20150922 | 0 | ||
| 126104641 | 12610464 | 2 | 20150922 | 0 | ||
| 126104641 | 12610464 | 3 | 20150922 | 0 | ||
| 126104641 | 12610464 | 4 | 20150922 | 0 | ||
| 126104641 | 12610464 | 6 | 20150922 | 0 | ||
| 126104641 | 12610464 | 9 | 20150922 | 0 |